Effect of piperine in the regulation of obesity-induced dyslipidemia in high-fat diet rats

Indian Journal of Pharmacology

Volumn 43, Issue 3, 2011, Pages 296-299

  Shah, Shreya S ^a   Shah, Gaurang B ^b   Singh, Satbeer D ^c   Gohil, Priyanshi V ^b   Chauhan, Kajal ^a   Shah, Khyati A ^a   Chorawala, Mehul ^b  

^a KB Raval College of Pharmacy   (India)

^b K B INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

^c V I VERNADSKY CRIMEAN FEDERAL UNIVERSITY   (Russian Federation)

Author keywords

Dyslipidemia; high fat diet; melanocortin 4; obesity; piperine

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PIPERINE; SIBUTRAMINE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DYSLIPIDEMIA; FOOD INTAKE; LIPID DIET; MALE; NONHUMAN; OBESITY; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79958251199     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.81516     Document Type: Article

References (20)

1. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2003;289:187-93. (Pubitemid 36068706)
2. Kushner R, Roth J. Assessment of the obese patient. Endocrinol Metab Clin North Am 2003;32:915-33. (Pubitemid 38029987)
3. Saper CB, Chou TC, Elmquist, JK. The need to feed: Homeostatic and hedonic control of eating. Neuron 2002;36:199-211. (Pubitemid 35217887)
4. Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, Williams T, et al.. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 2005;123:493-505. (Pubitemid 41546678)
5. Foster-Schubert KE, Cummings DE. Emerging therapeutic strategies for obesity. Endocr Rev 2006;27:779-93. (Pubitemid 44936060)
6. Schwartz MW, Woods SC, Porte JD, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000;404:661-71. (Pubitemid 30205071)
7. Cone RD, Lu D, Koppula S, Vage DI, Klungland H, Boston B, et al.. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog Horm Res 1996;51:287-317. (Pubitemid 126476618)
8. Bays H. The melanocortin system as a therapeutic treatment target for adiposity and adiposopathy. Drugs R D 2006;7:289-302. (Pubitemid 44291078)
9. Sharma G, Mishra B. Piperine- A therapeutic agent and bioavalibility enhancer. J Pharm Res 2007;6:129-33.
10. Vijayakumar RS, Namasivayam N. Lipid-lowering effi cacy of piperine from Piper nigrum L. in high-fat diet and antithyroid drug-induced hypercholesterolemic rats. J Food Biochem 2006;30:405-21.
11. Srinivasan K, Viswanad B, Lydia A, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening. Pharmacol Res 2005;52:313-20. (Pubitemid 41175991)
12. Banno R, Arima H, Hayashi M, Goto M, Watanabe M, Sato I. Central administration of melanocortin agonist increased insulin sensitivity in diet-induced obese rats. FEBS Lett 2007;581:1131-6. (Pubitemid 46385935)
13. Riccardi G, Giacco R, Rivellese AA. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 2004;23:447-56. (Pubitemid 39107022)
14. Srinivasan K, Patole PS, Kaul CL, Ramarao P. Reversal of glucose intolerance by pioglitazone in high-fat diet fed rats. Exp Clin Pharmacol 2004;26:327-33. (Pubitemid 38954807)
15. Storlien LH, James DE, Burleigh KM, Chisholm DJ, Kraegen EW. Fat feeding causes widespread in-vivo insulin resistance, decreased energy expenditure and obesity in the rat. Am J Physiol 1986;251:E576-83.
16. Despres JP, Krauss RM. Obesity and lipoprotein metabolism. In: Bray GA, Bouchard C, editors. Handbook of obesity. NewYork: Marcel Dekker; 2003. p. 41-5.
17. Howard BV, Ruotolo G, Robbins DC. Obesity and dyslipidemia. Endocrinol Metab Clin North Am 2003;32:855-67. (Pubitemid 38029984)
18. Shafrir E. Diabetes in animals: Contribution to the und erstanding of diabetes by study of its etiopathology in animal models. In: Porte D, Sherwin RS, Baron A, editors. Diabetes mellitus. NewYork: McGraw-Hill; 2003. p. 231-55.
19. Colca JR, Dailey CF, Palazuk BJ, Hillman RM, Dinh DM, Melchior GW. Pioglitazone hydrochloride inhibits cholesterol absorption and lowers plasma cholesterol concentrations in cholesterol fed rats. Diabetes 1991;40:1669-74.
20. Vijayakumar RS, Nalini N. Piperine, an active principle from Piper nigrum, modulates hormonal and apo lipoprotein profi les in hyperlipidemic rats. J Basic Clin Physiol Pharmacol 2006;17:71-86. (Pubitemid 44048040)